Primary Record
LOXORIBINE
- In stock
- 9,175 g
- Purity
- 98.4 %
- CAS
- 121288-39-9
Compound Identifiers & Properties
- CAS
- 121288-39-9
- PubChem CID
- 135410906
- SMILES
- C=CCN1C2=C(N=C(NC2=O)N)N(C1=O)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O
- Canonical SMILES
- C=CCn1c(=O)n([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2nc(N)[nH]c(=O)c21
Names & Synonyms
- LOXORIBINE
- Loxoribina
- 7-allyl-8-oxoguanosine
- Loxoribinum
- 121288-39-9
- (Loxoribine)
- 7a8oGuo
- (Loxoribine)"
- RWJ 21757
- RWJ-21757
- 7A8OGua
- 7-Allyl-7,8-dihydro-8-oxoguanosine
- Loxoribine [USAN:INN]
- Loxoribinum [INN-Latin]
- 9CAS0V66OI
- Loxoribina [INN-Spanish]
- Loxoribine < Rec INN
- UNII-9CAS0V66OI
- DTXSID3046748
- AC1L1TTN
- AC1Q6MTX
- LOXORIBINE [INN]
- Loxoribine (USAN/INN)
- RefChem:924942
- LOXORIBINE [USAN]
- D04EIF
- VDCRFBBZFHHYGT-IOSLPCCCSA-N
- SCHEMBL61782
- DTXCID1026748
- 7-Allyl-78-dihydro-8-oxoguanosine
- C13H17N5O6
- CHEMBL292008
- GTPL5018
- SCHEMBL16516342
- 7-Allyl-8-oxo-7,8-dihydroguanosine
- MFCD00867591
- GLXC-07304
- HMS3413D12
- HMS3677D12
- 7,8-dihydro-8-oxo-7-allyl-guanosine
- CID60737
- ZINC4674533
- Tox21_112592
- 7-allyl-7,8-dihydro-8-oxo-guanosine
- AKOS024284397
- AKOS040741970
- C13-H17-N5-O6
- Tox21_112592_1
- NA07175
- Guanosine, 7,8-dihydro-8-oxo-7-(2-propenyl)-
- NCGC00167840-01
- NCGC00263547-01
- 7,8-Dihydro-8-oxo-7-(2-propenyl)guanosine
- DA-55021
- SID:53789459
- ST075699
- SY347009
- CID:135410906
- HY-108472
- J519.305B
- 7-Allyl-7,8-dihydro-8-oxoguanosine, 95%
- CAS-121288-39-9
- CS-0028896
- FT-0661508
- NS00121470
- 7-(2-Propenyl)-8-oxo-7,8-dihydroguanosine
- 7-ALLYL-7 8-DIHYDRO-8-OXOGUANOSINE 95
- D04787
- 7-ALLYL-7 8-DIHYDRO-8-OXOGUANOSINE 95
- 7-Allyl-7,8-dihydro-8-oxoguanosine(Loxoribine)
- 8-Oxo-7-(prop-2-en-1-yl)-7,8-dihydroguanosine
- A945142
- C068562
- SR-01000883708
- 7-Allyl-2-amino-9-beta-D-ribofuranosylpurine-6,8(1H,9H)-dione
- SR-01000883708-1
- BRD-K00091711-001-01-2
- BRD-K00091711-001-02-0
- Q27081526
- 2-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-enyl-1H-purine-6,8-dione
- 2-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-enyl-3H-purine-6,8-dione
- 2-Azanyl-9-[(2~{r},3~{r},4~{s},5~{r})-5-(Hydroxymethyl)-3,4-Bis(Oxidanyl)oxolan-2-Yl]-7-Prop-2-Enyl-1~{h}-Purine-6,8-Dione
- AOG
- 2-amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-7-(prop-2-en-1-yl)-6,7,8,9-tetrahydro-3H-purine-6,8-dione
- 2-AMINO-9-[(2R,3R,4S,5R)-3,4-DIHYDROXY-5-(HYDROXYMETHYL)OXOLAN-2-YL]-7-(PROP-2-EN-1-YL)-1H-PURINE-6,8-DIONE
- 2-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-(prop-2-en-1-yl)-6,7,8,9-tetrahydro-1H-purine-6,8-dione
- 2-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-(prop-2-en-1-yl)-6,7,8,9-tetrahydro-3H-purine-6,8-dione
- 7-allyl-2-amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)-1H-purine-6,8(7H,9H)-dione
- 7-allyl-2-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-3H-purine-6,8-dione
- 9-[(4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-amino-7-prop-2- enyl-1,7-dihydropurine-6,8-dione
- SDL